Evaluation of Optimal Treatment Duration of Bevacizumab Combination With Standard Chemotherapy in Patients With Ovarian Cancer

Clinical trial NCT01462890 · COMPLETED

Trial details

NCT number: NCT01462890
Sponsor: AGO Study Group
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Genital Diseases, Female Ovarian Diseases Ovarian Neoplasms Fallopian Tube Neoplasms Peritoneal Neoplasms

Start date: 2011-11-01
Primary completion: 2020-12-31
Enrollment: 927

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.